News in the Life Sciences Industry

PALO ALTO, Calif., May 26, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management will present a corporate update at the Jefferies... Read more ››

FRANKLIN LAKES, N.J., May 26, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 11:00 a.m. ET.

FARMINGTON, Conn., May 26, 2020 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information... Read more ››

DUBLIN, May 26, 2020 /PRNewswire/ -- The Read more ››

NEW YORK, May 26, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) today announced that it will host an investor conference call and webcast to give an update on Bryostatin and the recently proposed merger between Neurotrope and Metuchen Pharmaceuticals, L.L.C. to form Petros Pharmaceuticals,... Read more ››

NEW YORK, May 26, 2020 /PRNewswire/ -- Prime Home Health Services, a modern certified home care agency, has recently launched at-home monitoring of COVID-19 patients, tracking their health remotely through technology from MonitorMe, an all-in-one health and wellness concierge monitoring program.... Read more ››

BOSTON, May 26, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, CEO,... Read more ››

DUBLIN, May 26, 2020 /PRNewswire/ -- The Read more ››

NEWARK, Del., May 26, 2020 /PRNewswire/ -- Today, the National Institute for Innovation in Biopharmaceutical Manufacturing (NIIMBL) announces that they have received $8.9 million from the U.S. Department of Commerce's National Institute of Standards and Technology (NIST). This award will fund... Read more ››